USANA Health Sciences, Inc.: Business Overview, Financials & Competitive Analysis
USANA Health Sciences, Inc. scores 6/10 on the AskCyborg Cyborg Score (Solid). USANA is transitioning from direct-selling dependency to omnichannel model with growing retail presence, balancing near-term margin headwinds against longer-term growth optionality. Despite 8% net sales growth to $925M, net earnings fell 74% to $10.8M, reflecting margin compression. Leadership returned Kevin Guest as CEO, signaling renewed strategic focus. The.
What is USANA Health Sciences, Inc.'s industry? USANA Health Sciences, Inc. (usana.com) operates in Nutritional Supplements, Functional Foods & Direct Selling. AskCyborg classifies USANA Health Sciences, Inc. under Nutritional Supplements, Functional Foods & Direct Selling in its company registry.
USANA develops and manufactures high-quality nutritional supplements, functional foods and personal care products that are sold directly to Brand Partners and Preferred Customers across 25 global markets. 2025 net sal...
Cyborg Score thesis
USANA is transitioning from direct-selling dependency to omnichannel model with growing retail presence, balancing near-term...
Read the full analyst-debate transcript →Get the Latest USANA Health Sciences, Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeUSANA Health Sciences, Inc. Overview
Pro stress-test →USANA develops and manufactures high-quality nutritional supplements, functional foods and personal care products that are sold directly to Brand Partners and Preferred Customers across 25 global markets. 2025 net sales grew 8% to $925M, though the company faces margin pressures from its evolving business model.
Strategic Profile
Pro stress-test →USANA is executing a diversification strategy towards an omnichannel model designed to support growth beyond its core nutritional business and to restructure and modernize operations for today's evolving marketplace. Net sales outside of the core nutritional business represented 16% of consolidated net sales in 2025, up from approximately 1% in 2024, with expectations to increase to more than 20% in fiscal 2026.
Competitive Landscape
Pro stress-test →USANA competes in the nutritional supplements and functional foods space across 25 global markets, competing with both traditional supplement companies and emerging direct-to-consumer/retail brands. The company's primary competitive advantage lies in its in-house manufacturing capability and multi-brand portfolio spanning direct-selling, retail, and children's health segments.
Industry Context
USANA Health Sciences, Inc. operates in Nutritional Supplements, Functional Foods & Direct Selling.
Key facts
Founded: 1992 · Headquarters: Salt Lake City, Utah · Revenue: $925M (FY2025)